Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.44% | 8.18% | 6.56% | -0.18% | -0.34% |
| Total Depreciation and Amortization | -2.52% | -0.73% | 1.30% | 14.17% | 34.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.89% | 37.00% | 41.43% | 36.91% | 39.27% |
| Change in Net Operating Assets | -40.42% | -75,760.00% | -424.79% | -19.78% | -565.25% |
| Cash from Operations | 11.34% | 8.55% | 8.35% | 5.21% | 2.25% |
| Capital Expenditure | 17.27% | 25.91% | 81.76% | 90.73% | 93.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.68% | -137.44% | -55.53% | -57.54% | -52.10% |
| Cash from Investing | -97.68% | -140.07% | -53.40% | -51.96% | -41.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 949.43% | -41.54% | -41.58% | -33.99% | -94.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 1,079.28% | -41.18% | -41.22% | -33.57% | -94.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.59% | -254.74% | -139.11% | -127.82% | -186.51% |